Sexual function post-breast cancer

Lauren F Streicher*, James A. Simon

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages167-189
Number of pages23
DOIs
StatePublished - Jan 1 2018

Publication series

NameCancer Treatment and Research
Volume173
ISSN (Print)0927-3042

Fingerprint

Breast Neoplasms
Libido
Aptitude
Arousal
Estrogens
Therapeutics
Radiation
Drug Therapy

Keywords

  • DHEA
  • Dyspareunia
  • Female sexual dysfunction
  • Fractional CO2 laser
  • Genitourinary syndrome of menopause
  • Hypoactive sexual desire disorder
  • Ospemifene
  • Prasterone
  • Vaginal estrogen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Streicher, L. F., & Simon, J. A. (2018). Sexual function post-breast cancer. In Cancer Treatment and Research (pp. 167-189). (Cancer Treatment and Research; Vol. 173). Springer International Publishing. https://doi.org/10.1007/978-3-319-70197-4_11
Streicher, Lauren F ; Simon, James A. / Sexual function post-breast cancer. Cancer Treatment and Research. Springer International Publishing, 2018. pp. 167-189 (Cancer Treatment and Research).
@inbook{22c942ede82f4f90a21d1805c5a24536,
title = "Sexual function post-breast cancer",
abstract = "The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.",
keywords = "DHEA, Dyspareunia, Female sexual dysfunction, Fractional CO2 laser, Genitourinary syndrome of menopause, Hypoactive sexual desire disorder, Ospemifene, Prasterone, Vaginal estrogen",
author = "Streicher, {Lauren F} and Simon, {James A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-70197-4_11",
language = "English (US)",
series = "Cancer Treatment and Research",
publisher = "Springer International Publishing",
pages = "167--189",
booktitle = "Cancer Treatment and Research",

}

Streicher, LF & Simon, JA 2018, Sexual function post-breast cancer. in Cancer Treatment and Research. Cancer Treatment and Research, vol. 173, Springer International Publishing, pp. 167-189. https://doi.org/10.1007/978-3-319-70197-4_11

Sexual function post-breast cancer. / Streicher, Lauren F; Simon, James A.

Cancer Treatment and Research. Springer International Publishing, 2018. p. 167-189 (Cancer Treatment and Research; Vol. 173).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Sexual function post-breast cancer

AU - Streicher, Lauren F

AU - Simon, James A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

AB - The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

KW - DHEA

KW - Dyspareunia

KW - Female sexual dysfunction

KW - Fractional CO2 laser

KW - Genitourinary syndrome of menopause

KW - Hypoactive sexual desire disorder

KW - Ospemifene

KW - Prasterone

KW - Vaginal estrogen

UR - http://www.scopus.com/inward/record.url?scp=85041066923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041066923&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-70197-4_11

DO - 10.1007/978-3-319-70197-4_11

M3 - Chapter

C2 - 29349764

AN - SCOPUS:85041066923

T3 - Cancer Treatment and Research

SP - 167

EP - 189

BT - Cancer Treatment and Research

PB - Springer International Publishing

ER -

Streicher LF, Simon JA. Sexual function post-breast cancer. In Cancer Treatment and Research. Springer International Publishing. 2018. p. 167-189. (Cancer Treatment and Research). https://doi.org/10.1007/978-3-319-70197-4_11